TCL Archive Genentech Reps Not Welcome: Hospitals Urge Drug Maker to Reverse Policy On Supplying Avastin, Rituxan, & Herceptin October 17, 2014
TCL Archive Somatuline Demonstrates 65.1 Percent Of Patients Progression-Free at 96 Weeks July 25, 2014
TCL Archive Studies Question PSA Screening: PLCO Trial Finds No Survival Advantage, European Trial Finds Benefit At High Cost March 20, 2009
